OpenURL Connection Search

Select item for more details and to access through your institution.

Two-Front War on Cancer—Targeting TAM Receptors in Solid Tumour Therapy.
Published in:
Cancers, 2022, v. 14, n. 10, p. 2488, doi. 10.3390/cancers14102488
By:
- Mikolajczyk, Agata;
- Mitula, Filip;
- Popiel, Delfina;
- Kaminska, Bozena;
- Wieczorek, Maciej;
- Pieczykolan, Jerzy
Publication type:
Article
Improved cytotoxicity of novel TRAIL variants produced as recombinant fusion proteins.
Published in:
PEDS: Protein Engineering, Design & Selection, 2018, v. 31, n. 2, p. 37, doi. 10.1093/protein/gzx065
By:
- Figiel, Małgorzata;
- Bonarek, Piotr;
- Górecki, Andrzej;
- Pawlak, Sebastian D.;
- Żerek, Bartłomiej;
- Cheçiń ska, Beata;
- Pieczykolan, Jerzy;
- Dziedzicka-Wasylewska, Marta
Publication type:
Article
A PDE10A inhibitor CPL500036 is a novel agent modulating striatal function devoid of most neuroleptic side-effects.
Published in:
Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.999685
By:
- Matloka, Mikolaj;
- Janowska, Sylwia;
- Pankiewicz, Piotr;
- Kokhanovska, Sofiya;
- Kos, Tomasz;
- Hołuj, Małgorzata;
- Rutkowska-Wlodarczyk, Izabela;
- Abramski, Krzysztof;
- Janicka, Monika;
- Jakubowski, Piotr;
- Świątkiewicz, Maciej;
- Welniak-Kaminska, Marlena;
- Hucz-Kalitowska, Joanna;
- Dera, Paulina;
- Bojarski, Lukasz;
- Grieb, Paweł;
- Popik, Piotr;
- Wieczorek, Maciej;
- Pieczykolan, Jerzy
Publication type:
Article
Evaluation of the hepatotoxicity of the novel GPR40 (FFAR1) agonist CPL207280 in the rat and monkey.
Published in:
PLoS ONE, 2021, v. 16, n. 9, p. 1, doi. 10.1371/journal.pone.0257477
By:
- Bazydlo-Guzenda, Katarzyna;
- Buda, Pawel;
- Mach, Mateusz;
- Pieczykolan, Jerzy;
- Kozlowska, Izabela;
- Janiszewski, Michal;
- Drzazga, Ewa;
- Dominowski, Jakub;
- Ziolkowski, Hubert;
- Wieczorek, Maciej;
- Gad, Shayne Cox
Publication type:
Article
Preclinical characterization of CPL302-253, a selective inhibitor of PI3Kδ, as the candidate for the inhalatory treatment and prevention of Asthma.
Published in:
PLoS ONE, 2020, v. 15, n. 7, p. 1, doi. 10.1371/journal.pone.0236159
By:
- Gunerka, Paweł;
- Gala, Kamila;
- Banach, Martyna;
- Dominowski, Jakub;
- Hucz-Kalitowska, Joanna;
- Mulewski, Krzysztof;
- Hajnal, Agnes;
- Mikus, Endre G.;
- Smuga, Damian;
- Zagozda, Marcin;
- Dubiel, Krzysztof;
- Pieczykolan, Jerzy;
- Zygmunt, Beata M.;
- Wieczorek, Maciej
Publication type:
Article
2333-PUB: CPL207-280, a Potent and Safe GPR40 Agonist for the treatment of Type 2 Diabetes.
Published in:
Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2333-PUB
By:
- BAZYDLO-GUZENDA, KATARZYNA;
- BUDA, PAWEL;
- KOZLOWSKA, IZABELA;
- MACH, MATEUSZ;
- TESKA-KAMINSKA, MALGORZATA;
- STELMACH, FILIP;
- WASINSKA-KALWA, MALGORZATA;
- GALAZKA, KINGA;
- DUBIEL, KRZYSZTOF K.;
- PIECZYKOLAN, JERZY S.;
- WIECZOREK, MACIEJ
Publication type:
Article
AD-O53.2-a novel recombinant fusion protein combining the activities of TRAIL/Apo2L and Smac/Diablo, overcomes resistance of human cancer cells to TRAIL/Apo2L.
Published in:
Investigational New Drugs, 2014, v. 32, n. 6, p. 1155, doi. 10.1007/s10637-014-0153-y
By:
- Pieczykolan, Jerzy;
- Kubiński, Konrad;
- Masłyk, Maciej;
- Pawlak, Sebastian;
- Pieczykolan, Anna;
- Rózga, Piotr;
- Szymanik, Michał;
- Gałązka, Marlena;
- Teska-Kamińska, Małgorzata;
- Żerek, Bartłomiej;
- Bukato, Katarzyna;
- Poleszak, Katarzyna;
- Jaworski, Albert;
- Strożek, Wojciech;
- Świder, Robert;
- Zieliński, Rafał
Publication type:
Article
Correction: Serwotka-Suszczak, A. M. et al. A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer Cells. Int. J. Mol. Sci. 2017, 18, 401.
Published in:
2018
By:
- Serwotka-Suszczak, Anna M.;
- Sochaj-Gregorczyk, Alicja M.;
- Pieczykolan, Jerzy;
- Krowarsch, Daniel;
- Jelen, Filip;
- Otlewski, Jacek
Publication type:
Correction Notice
A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer Cells.
Published in:
International Journal of Molecular Sciences, 2017, v. 18, n. 2, p. 401, doi. 10.3390/ijms18020401
By:
- Serwotka-Suszczak, Anna M.;
- Sochaj-Gregorczyk, Alicja M.;
- Pieczykolan, Jerzy;
- Krowarsch, Daniel;
- Jelen, Filip;
- Otlewski, Jacek
Publication type:
Article
Novel engineered TRAIL‐based chimeric protein strongly inhibits tumor growth and bypasses TRAIL resistance.
Published in:
International Journal of Cancer, 2020, v. 147, n. 4, p. 1117, doi. 10.1002/ijc.32845
By:
- Rozga, Piotr;
- Kloska, Damian;
- Pawlak, Sebastian;
- Teska‐Kaminska, Malgorzata;
- Galazka, Marlena;
- Bukato, Katarzyna;
- Pieczykolan, Anna;
- Jaworski, Albert;
- Molga‐Kaczmarska, Anna;
- Kopacz, Aleksandra;
- Badyra, Bogna;
- Kachamakova‐Trojanowska, Neli;
- Zolnierkiewicz, Olga;
- Targosz‐Korecka, Marta;
- Poleszak, Katarzyna;
- Szymanik, Michal;
- Zerek, Bartlomiej;
- Pieczykolan, Jerzy;
- Jozkowicz, Alicja;
- Grochot‐Przeczek, Anna
Publication type:
Article

Found: 10